New

ETF model portfolios designed for real investor needs. Discover →

Advertisement
Advertisement

HTECvsPBEETF Comparison

ETF 1
HTEC

Robo Global Healthcare Technology and Innovation ETF

This fund is part of
Multiple Trends
-1.74%
VS
ETF 2
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
+2.4%

Robo Global Healthcare Technology and Innovation ETF (HTEC) belongs to the Multiple Trends segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. HTEC's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, PBE's top sector exposures are Healthcare. HTEC is more expensive with a Total Expense Ratio (TER) of 0.8%, versus 0.59% for PBE. HTEC is up 15.06% year-to-date (YTD) with +$11M in YTD flows. PBE performs better with 15.35% YTD performance, and +$114M in YTD flows. Run a side-by-side ETF comparison of HTEC and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

HTEC vs PBE performance and flow charts

Performance

-2.00.02.04.06.0%Aug 11Aug 18Aug 25Sep 1Sep 9

Cumulative Flows

0 M20 M40 M60 M80 MAug 11Aug 18Aug 25Sep 1Sep 9

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/11/2026
1M3MYTD1Y3Y5Y
Perf.
HTEC
PBE
-1.16%-0.03%
+16.38%+11.40%
+15.06%+15.35%
+32.43%+37.16%
+50.15%+58.59%
-14.71%+26.94%
Flows
HTEC
PBE
-$1K+$27M
+$7M+$117M
+$11M+$114M
+$10M+$113M
-$29M+$62M
-$93M+$64M
Volatility and drawdown
3M1Y3Y5Y
Volatility
HTEC
PBE
+22.41%+19.39%
+21.04%+19.15%
+20.93%+20.49%
+24.23%+22.56%
Max drawdown
HTEC
PBE
-6.70%-5.97%
-16.84%-11.70%
-22.68%-22.21%
-55.10%-33.32%
Max drawdown duration
HTEC
PBE
17d11d
160d166d
237d324d
1818d1509d
Trading data

Create an account to view trading data

Join for free
HTEC
PBE
Last sale
9/15/2026 at 1:56 PM
$41.37
$93.45
Previous close
09/14/2026
$41.44
$93.64
Consolidated volume
09/14/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
HTEC
PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/15/2026 at 1:56 PM
Live
Closed
HTEC
PBE
Last price
$41.37
$93.45
1D performance
-0.16%
-0.20%
AuM$73.42 M$408.56 M
E/R0.8%0.59%
Characteristics
HTEC
PBE
Management strategyPassivePassive
ProviderROBO Global ETFsInvesco
BenchmarkROBO Global Healthcare Technology and InnovationDynamic Biotech & Genome Intellidex Index
N° of holdings6330
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 25, 2019June 23, 2005
ESGYesNo
Advertisement
Exposure

Countries

HTEC
USA
75.7%
Other
24.3%
PBE
USA
97.13%
Other
2.87%

Sectors

HTEC
Healthcare
94.38%
Other
5.62%
PBE
Healthcare
100%
Other
0%
Advertisement

Diversification

HTEC

Total weight of top 15 holdings out of 15

31.72%
PBE

Total weight of top 15 holdings out of 15

61.32%

Top 15 holdings

Data as of July 31, 2026
HTEC
CareDx, Inc.
2.68%
Guardant Health, Inc.
2.32%
Natera, Inc.
2.23%
Twist Bioscience Corp.
2.23%
Thermo Fisher Scientific, Inc.
2.18%
Medpace Holdings, Inc.
2.12%
Adaptive Biotechnologies Corp.
2.11%
IQVIA Holdings, Inc.
2.10%
Illumina, Inc.
2.09%
Arrowhead Pharmaceuticals, Inc.
2.08%
Regeneron Pharmaceuticals, Inc.
1.97%
Glaukos Corp.
1.92%
Vertex Pharmaceuticals, Inc.
1.91%
Stryker Corp.
1.91%
LivaNova Plc
1.87%
PBE
Amgen, Inc.
5.16%
Vertex Pharmaceuticals, Inc.
4.96%
Royalty Pharma Plc
4.91%
Regeneron Pharmaceuticals, Inc.
4.90%
Biogen, Inc.
4.85%
Gilead Sciences, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.34%
United Therapeutics Corp.
4.06%
CareDx, Inc.
4.01%
Bio-Techne Corp.
3.66%
Illumina, Inc.
3.27%
Vericel Corp.
3.25%
Protagonist Therapeutics, Inc.
3.24%
Incyte Corp.
3.19%
Veracyte, Inc.
3.07%
Frequently asked questions about HTEC and PBE

How have the HTEC and PBE ETFs performed in 2026?

As of September 11, 2026, HTEC is up 15.06% year-to-date (YTD), while PBE has returned 15.35%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: HTEC or PBE?

Year-to-date, the HTEC ETF saw +$11M in flows, compared to +$114M for PBE.

Which ETF is more volatile: HTEC or PBE?

Over the past year, HTEC had a volatility of 21.04%, while PBE experienced 19.15%.

Which ETF is bigger: HTEC or PBE?

As of September 11, 2026, HTEC holds $73.42 M in assets under management (AUM), while PBE manages $408.56 M.

What sectors do the HTEC and PBE ETFs invest in?

HTEC leans toward sectors like Healthcare. Meanwhile, PBE focuses on Healthcare.

What are the top holdings of the HTEC ETF and PBE ETF?

HTEC top holdings include CareDx, Inc., Guardant Health, Inc. and Natera, Inc.. PBE holds in its top three: Amgen, Inc., Vertex Pharmaceuticals, Inc. and Royalty Pharma Plc.

Which ETF is more diversified: HTEC or PBE?

HTEC holds 63 securities with 31.72% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 61.32%.

Advertisement
Latest news about HTEC & PBE
Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder